Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topics
- Shortages and supply disruptions (15)
- Safety monitoring and information (10)
- Manufacturing (7)
- Compliance and enforcement (6)
- Labelling and packaging (4)
- Import and export (3)
- Legislation (3)
- Scheduling (national classification system) (3)
- Committees and advisory bodies (2)
- Advertising (1)
- Clinical trials (1)
- Fees and payments (1)
- Medicinal cannabis hub (1)
- Weight loss products (1)
Collection content
109 result(s) found, displaying 51 to 60
-
PageSearch the Code Tables for codes needed to apply for good manufacturing practice (GMP) clearance.
-
GuidanceGuidance on submitting an effective prescription medicines application.
-
GuidanceGuidance on the process and regulatory requirements to register prescription medicines.
-
PageImportant information on the Database of TGA Laboratory testing results.
-
GuidanceThis guidance is for sponsors and manufacturers supplying medicines in Australia that are serialised or have data matrix codes.
-
GuidanceGuidance on obligations during provisional registration period, process for applying for extension of provisional registration and transition to full registration.
-
GuidanceThis guidance explains the administrative and prescribing (dossier) information you need to support the registration or variation of a prescription medicine.
-
-
GuidanceGuidance on how the Poisons Standard is amended and the processes that underpin scheduling policy
-
GuidanceRisk management plans for medicines and biologicals has been updated with new content, new Australia-Specific Annex and a new form.